Supernus Pharmaceuticals, Inc. (SUPN)

53.30 +2.61 (+5.15%) USD  |  NASDAQ  |  Feb 24, 16:00
55.00 +1.70 (+3.19%) After-Hours: 20:00
More

Supernus Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Oncotelic Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Krystal Biotech, Inc. Upgrade